GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
about
Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D betaGR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptorL-694,247: a potent 5-HT1D receptor agonistOn serotonin and migraine: a clinical and pharmacological reviewGR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitroInfluence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar arteryMolecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptorPharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive ratOne hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation.The discovery of a new drug class for the acute treatment of migraine.Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogsThe 5-HT1-like receptor mediating the increase in canine external carotid blood flow: close resemblance to the 5-HT1D subtype.Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical arteryMolecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT(1D) receptorFrom serotonin receptor classification to the antimigraine drug sumatriptan.The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs.5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors.Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.Sumatriptan-induced saphenous venoconstriction in the anaesthetized dog through 5-HT1-like receptor activationPotentiation of responses to sympathetic nerve stimulation and vasoconstrictor agents by SK&F 103829 in the feline mesenteric circulation.Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxaneSumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein.The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura materAlpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate productionContractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sitesComparison of endothelium-dependent responses of monkey cerebral and temporal arteries.The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans?Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619Neuropharmacology of 5-hydroxytryptamine.Rationale for the use of 5-HT1-like agonists in the treatment of migraine.
P2860
Q24338360-205B7BB9-F3C7-4E78-BF02-D5E36FEBB309Q24679519-5863B46E-32D1-4FBC-8FAC-F079A27E8E1FQ24685732-29DFF66B-C96E-4A57-9BB5-861267F10B85Q28263827-97E2F0C4-FF64-4857-9059-679FE21F6325Q28341988-128BC161-94EF-48EB-8CF7-32F3320FBB5CQ28342316-2925CF39-7ADA-4ECF-ABF3-7307BAC7511EQ28343925-8F710307-A514-467E-B440-7810AF13089DQ28379361-EC4F9EF2-61AC-4C12-86B9-C8B1CEFE63CAQ34180539-3D9AC647-D876-4CFD-97CB-D2266BAD0FAAQ34307161-FFEFD7F4-FFCE-4B0A-BB74-8F85D1DD5E36Q34403370-4AF2F378-ED53-436E-BB31-998B97781BA2Q34617817-38B07983-C8CA-4AE0-9E96-62C782CD7361Q34662700-2E2DB7C1-7555-4320-9D05-C3524CFC7A85Q34732717-F6666004-AF15-4AA2-91E3-60B61499AF37Q34792265-9DF9D3D1-D7DD-4E88-B92A-EAA8A5E97CC3Q35026033-3BD767EC-C153-4255-8F8A-D19653E7BFD9Q35029098-7C0261C2-D5EB-45D8-B793-69B04329F85EQ35042842-CA24CB46-9753-44F1-8366-709C9BC16EACQ35233143-DF67613A-D35B-4D5A-959B-CCD3920413FCQ35756174-783D990A-8ACA-42BF-B141-C567B3E75759Q35756200-3235EABD-4991-4EF1-AECE-177632946F17Q35756243-3A60E5BE-FC5D-44D0-A24E-1883BA15F2E2Q35871228-DB7F599D-4565-49CD-B596-9B11EBC00A49Q35871242-28B4167B-1C39-4CF0-B1C2-93C2B8327FC7Q35871445-78D8AB62-E674-4CBD-A8D8-0353A8C78DEDQ35872010-29674CF7-2681-497D-938A-DD2EAA5F951FQ35872161-93FBA1F1-F1A7-44C5-8C1B-315B8ADBC597Q35872811-D04E64DF-07F2-49A0-8280-0EED887C9F71Q35872845-FFB1422C-1F52-4B0A-8610-DEC18F99BF1BQ35874284-0DC02003-5B42-46C1-9C9E-18D220016752Q35884789-8F82956B-3DAA-484D-9C68-28740620B9CAQ35887801-54A0C94A-4C08-42A6-81FC-E4923196CE6CQ35887963-4C34FDF2-4079-4349-B928-10EA8E76C351Q35888594-F0F83BF7-A573-415B-9A74-627420933AA8Q35888605-3A22A842-29C9-4ED4-840C-182508BDCA95Q35888719-CB4F2A49-8180-4135-A191-C47750F13880Q36053195-87AF6D7F-9A1F-4DAE-8147-C5FC52C6129FQ36330430-23E6B6F9-F454-4530-9981-7B119FC9F9F3Q36364408-64FADDB6-320C-4968-B7DA-15DC3EA62128Q36389341-2B794D92-7363-4892-A7DC-6F2F540402AF
P2860
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
@ast
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
@en
type
label
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
@ast
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
@en
prefLabel
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
@ast
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
@en
P2093
P2860
P1476
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein
@en
P2093
A W Oxford
H E Connor
L H Coates
M J Perren
P P Humphrey
P2860
P304
P356
10.1111/J.1476-5381.1988.TB11630.X
P407
P577
1988-08-01T00:00:00Z